期刊
BIOMATERIALS
卷 30, 期 18, 页码 3189-3196出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2009.02.030
关键词
Paclitaxel; Glioma; PLGA; Foams; In vivo bio-distribution; Sustained release
资金
- Office of Life Sciences, National University of Singapore [R-279-000-201-712]
- Biomedical Research Council, Singapore [BMRC/07/1/21/19/508, R-279-000-257-305]
Paclitaxel loaded biodegradable poly-(DL-lactic-co-glycolic) acid (PLGA) foams with micro porous matrix were fabricated by a novel pressure quenching approach to provide a sustained paclitaxel release. The foams with micropores provided increased surface area to volume ratio and were also implantable for post-surgical chemotherapy applications. The two formulations 5% (w/w) paclitaxel loaded PLGA 85:15 foam (F1) and 10% (w/w) paclitaxel loaded PLGA 50:50 foam (F2), were evaluated in vitro and in vivo. Both the foams were found to provide a paclitaxel release beyond a month in vitro with a near zero-order kinetics and with minimum burst release. Furthermore, apoptosis of C6 glioma cells in vitro demonstrated the benefits of sustained paclitaxel release by the foams in comparison to acute Taxol (R) exposure. Both the foams exhibited continuous paclitaxel release in an in vivo (subcutaneous) environment up to a month which correlated well with the in vitro release profiles. Bio-distribution results in the rat brain showed paclitaxel penetration at therapeutic levels up to 3 mm into the tissue from the site of foam implantation. Hence these foams could be employed as potential implants for post-surgical chemotherapy against malignant glioma. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据